X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-01 | EPIX | Biotech Growth N V | 10% | S - Sale | $1.53 | -7,879,583 | 0 | -100% | -$12,018,409 | ||||||
2024-10-07 | EPIX | Virsik Peter | COO | S - Sale | $6.03 | -694 | 7,776 | -8% | -$4,185 | ||||||
2024-09-09 | EPIX | Virsik Peter | COO | S - Sale | $6.00 | -694 | 8,470 | -8% | -$4,164 | ||||||
2024-09-03 | EPIX | Virsik Peter | COO | S - Sale | $6.03 | -2,082 | 9,164 | -19% | -$12,554 | ||||||
2024-05-06 | EPIX | Virsik Peter | COO | S - Sale | $6.95 | -694 | 11,246 | -6% | -$4,823 | ||||||
2024-04-05 | EPIX | Virsik Peter | COO | S - Sale | $7.94 | -694 | 11,940 | -5% | -$5,510 | ||||||
2024-03-05 | EPIX | Virsik Peter | COO | S - Sale | $8.98 | -694 | 12,634 | -5% | -$6,232 | ||||||
| D | 2024-02-06 | EPIX | Virsik Peter | COO | S - Sale+OE | $10.29 | -72,782 | 13,328 | -85% | -$748,927 | |||||
| D | 2024-02-05 | EPIX | Virsik Peter | COO | S - Sale+OE | $9.58 | -1,194 | 13,328 | -8% | -$11,440 | |||||
| D | 2024-01-16 | EPIX | Virsik Peter | COO | S - Sale+OE | $10.01 | -1,718 | 14,022 | -11% | -$17,197 | |||||
2024-01-05 | EPIX | Virsik Peter | COO | S - Sale | $6.11 | -699 | 14,022 | -5% | -$4,271 | ||||||
2023-12-14 | EPIX | Parkinson David Ross | CEO | P - Purchase | $2.30 | +9,223 | 65,675 | +16% | +$21,213 | ||||||
2023-11-21 | EPIX | Berger Franklin M | Dir | P - Purchase | $5.73 | +23,259 | 784,404 | +3% | +$133,274 | ||||||
| M | 2023-11-02 | EPIX | Berger Franklin M | Dir | P - Purchase | $5.49 | +76,471 | 760,875 | +11% | +$419,661 | |||||
| M | 2022-12-22 | EPIX | Parkinson David Ross | CEO | P - Purchase | $2.42 | +24,434 | 56,542 | +76% | +$59,041 | |||||
| M | 2022-12-14 | EPIX | Berger Franklin M | Dir | S - Sale | $2.67 | -272,840 | 684,404 | -29% | -$729,052 | |||||
2022-12-30 | EPIX | Wood David S. | CFO | P - Purchase | $2.60 | +8,302 | 33,343 | +33% | +$21,585 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |